Vital Signs - Drug Delivery: Current Challenges
Vital Signs - Drug Delivery: Current Challenges
RELEASE DATE
25-Aug-2008
25-Aug-2008
REGION
North America
North America
Research Code: 9561-00-6F-00-00
SKU: HC00542-NA-MR_04014
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00542-NA-MR_04014
Description
This issue of Vital Signs, released on August 25, 2008, provides an strategic overview of challenges relevant to drug delivery product design, valuation and commercial opportunity assessment for pharmaceutical & biotechnology companies. Additionally, a company spotlight is provided for Novocell, a stem cell engineering company dedicated to development, creation and commercialization of cell and drug based therapies for diabetes and other chronic diseases. Reimbursement and regulatory news from the FDA is also provided for the week of August 11, 2008.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on August 25, 2008, provides an strategic overview of challenges relevant to drug delivery product design, valuation and commercial opportunity assessment for pharmaceutical & biotechnology companies. Additionally, a company spotlight is provided for Novocell, a stem cell engineering company dedicated to development, creation and commercialization of cell and drug based therapies for diabetes and other chronic diseases. Reimbursement and regulatory news from the FDA is also provided for the week of August 11, 2008.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-6F-00-00 |
Is Prebook | No |